Andrew Ellis
Growth Equity Investor at Norwest Venture Partners
San Francisco, California
Andrew Ellis, Growth Equity Investor at Norwest Venture Partners is an active investor based in San Francisco, California. This profile covers what Andrew Ellis backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VC
- Stages
- Late Stage Venture
- Invests in
- SaaS & Enterprise
- Location
- San Francisco, California
- Typical check
- $7M
How to reach Andrew Ellis
Angels and operators like Andrew Ellis reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Connect with Andrew Ellis
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise.
Frequently Asked Questions
What does Andrew Ellis invest in?
Andrew Ellis invests in SaaS & Enterprise, typically at Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Andrew Ellis invest at?
Andrew Ellis typically invests at Late Stage Venture. Lead with traction that fits the stage when you reach out.
What is Andrew Ellis's typical check size?
Andrew Ellis typically writes checks around $7M. Use it as a signal for whether your raise fits their stage.
How do I contact Andrew Ellis?
Unlock Andrew Ellis's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.